|
Volumn 47, Issue SUPPL. 3, 2001, Pages 32-37
|
Latest industry information on the safety profile of levofloxacin in the US
|
Author keywords
ADRs; Clinical trials; Fluoroquinolones; Levofloxacin; PMS data; Safety; Toxicity
|
Indexed keywords
AZITHROMYCIN;
CEFTRIAXONE;
LEVOFLOXACIN;
MACROLIDE;
ABDOMINAL PAIN;
ANXIETY NEUROSIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONVULSION;
DRUG INFORMATION;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG USE;
FOOD AND DRUG ADMINISTRATION;
HEADACHE;
HUMAN;
INSOMNIA;
NAUSEA;
PRIORITY JOURNAL;
RASH;
TASTE DISORDER;
UNITED STATES;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANTI-INFECTIVE AGENTS;
CLINICAL TRIALS;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
OFLOXACIN;
REPRODUCIBILITY OF RESULTS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0034851910
PISSN: 00093157
EISSN: None
Source Type: Journal
DOI: 10.1159/000057842 Document Type: Conference Paper |
Times cited : (51)
|
References (0)
|